Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Gabriel Capital Management

Investor type Private Equity Firm

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$5M
Portfolio companies 1
Rounds per year 0.04
Lead investments 0
Exits 1
Key employees 1
Stages of investment
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
Summary

Gabriel Capital Management is the famous VC, which was founded in 1994. The venture was found in North America in United States. The main department of described VC is located in the New York.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - Israel. We can highlight the next thriving fund investment areas, such as Biotechnology, Pharmaceutical. Among the various public portfolio startups of the fund, we may underline Intec Pharma Besides, a startup needs to be aged 11-15 years to get the investment from the fund.

Besides them, we counted 1 critical employee of this fund in our database.

The standard case for the fund is to invest in rounds with 2 partakers. The meaningful sponsors for the fund in investment in the same round are Sphera Corporation. In the next rounds fund is usually obtained by ROTH Capital Partners, Oppenheimer & Co., Inc., Ladenburg Thalmann.

The increased amount of exits for fund were in 2015. The usual things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2013.

Read more

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
350 Capital Canada, Ontario, Toronto
ABB Switzerland, Zürich, Zurich
AVANA Capital Arizona, Glendale, United States
Blue Cloud Ventures New York, New York, United States
Cobis Great Falls, United States, Virginia
Echo Capital Canada, Montréal, Quebec
ENGIE New Ventures France, Ile-de-France, Paris
Guosheng Group China, Shanghai
Heyu Ziben China, Guangdong, Shenzhen
HLM Management Company Boston, Massachusetts, United States
ITX Corporation New York, Pittsford, United States
Jadebird Capital Beijing, Beijing, China
Manhuadao China, Minhang, Shanghai
Southeast Minnesota Capital Fund Minnesota, Rochester, United States
Starharbor Asia -
The Arena Capital China, Shanghai
Xinlan Investment Beijing, Changping, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Intec Pharma

Biotechnology
Health Care
Pharmaceutical
$5M19 Aug 2013 Jerusalem District

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Gabriel Capital Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: